"Costs and benefits of shared fractionation of bevacizumab for the treatment of retinal vascular diseases" (Master's). Candidate: Sávio Lima Sodré. Advisor: professor Jose Paulo Cabral de Vasconcellos. December 4, 2019, at 14 pm, in the HC Otorhinolaryngology auditorium.
Costs and benefits of shared fractionation of bevacizumab for the treatment of retinal vascular diseases
